Agenus (FRA:AJ8) Cyclically Adjusted Book per Share: €-13.34 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AJ8 Agenus Inc FRA:AJ8
48 GF Score
Price €6.10
GF Value €3.22
Valuation Significantly Overvalued
! 12 Warning Signs
View Full Analysis

What is Agenus Cyclically Adjusted Book per Share?

Agenus FRA:AJ8 -3.94% 48 Cyclically Adjusted Book per Share is €-13.34 as of Jun. 2026. GuruFocus rates FRA:AJ8 with a GF Score™ of 48/100 and a GF Value™ of €3.22 (Significantly Overvalued). The stock has 12 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Agenus's adjusted book value per share for the three months ended in Jun. 2026 was €-3.861. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-13.34 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -24.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -7.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Agenus was 25.90% per year. The lowest was -42.10% per year. And the median was 9.10% per year.

As of today (2026-08-18), Agenus's current stock price is €6.10. Agenus's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €-13.34. Agenus's Cyclically Adjusted PB Ratio of today is .


Agenus  (FRA:AJ8) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Agenus Cyclically Adjusted Book per Share Related Terms


Agenus Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Agenus's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agenus Cyclically Adjusted Book per Share Chart

Agenus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.86 -6.41 -5.98 -10.02 -11.91

Agenus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.83 -11.13 -11.91 -12.60 -13.34

FRA:AJ8 vs FULC, IRD, TTRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Agenus's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agenus Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Agenus's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Agenus's Cyclically Adjusted PB Ratio falls into.


FRA:AJ8
48GF Score
Agenus Inc FRA:AJ8
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agenus Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Agenus's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-3.861/333.9520*333.9520
=-3.861

Current CPI (Jun. 2026) = 333.9520.

Agenus Quarterly Data

Book Value per Share CPI Adj_Book
201609 -4.303 241.428 -5.952
201612 -8.449 241.432 -11.687
201703 1.687 243.801 2.311
201706 -3.124 244.955 -4.259
201709 -8.680 246.819 -11.744
201712 -12.599 246.524 -17.067
201803 -17.807 249.554 -23.829
201806 -17.352 251.989 -22.996
201809 -18.885 252.439 -24.983
201812 -25.266 251.233 -33.585
201903 -15.317 254.202 -20.122
201906 -20.275 256.143 -26.434
201909 -26.400 256.759 -34.337
201912 -29.433 256.974 -38.250
202003 -21.716 258.115 -28.096
202006 -22.650 257.797 -29.341
202009 -17.817 260.280 -22.860
202012 -17.075 260.474 -21.892
202103 -14.625 264.877 -18.439
202106 -18.211 271.696 -22.384
202109 2.875 274.310 3.500
202112 2.373 278.802 2.842
202203 1.070 287.504 1.243
202206 0.229 296.311 0.258
202209 -1.396 296.808 -1.571
202212 -3.786 296.797 -4.260
202303 -3.200 301.836 -3.540
202306 -4.681 305.109 -5.124
202309 -6.344 307.789 -6.883
202312 -7.456 306.746 -8.117
202403 -8.827 312.332 -9.438
202406 -10.611 314.175 -11.279
202409 -12.146 315.301 -12.864
202412 -13.188 315.605 -13.955
202503 -11.904 319.799 -12.431
202506 -10.247 322.561 -10.609
202509 -7.118 324.800 -7.319
202512 -6.555 324.054 -6.755
202603 -4.967 330.213 -5.023
202606 -3.861 333.952 -3.861

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-13.34 mean?
Agenus (FRA:AJ8) has a Cyclically Adjusted Book per Share of €-13.34 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Agenus and its competitors.
Is Agenus' Cyclically Adjusted Book per Share too high?
Agenus' current Cyclically Adjusted Book per Share is €-13.34. Overall, Agenus has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agenus' Cyclically Adjusted Book per Share compare to FULC and IRD?
Agenus' Cyclically Adjusted Book per Share of €-13.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Agenus and its competitors. Agenus's current Cyclically Adjusted Book per Share is €-13.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agenus stock overvalued right now?
Based on GuruFocus' analysis, Agenus (FRA:AJ8) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.22, compared to a current price of €6.10 — trading 89.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is €-13.34. Agenus' overall GF Score™ is 48/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Agenus (FRA:AJ8), the current Cyclically Adjusted Book per Share is €-13.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agenus (FRA:AJ8) Overvalued in 2026?

Based on GuruFocus' analysis, Agenus stock appears to be overvalued. The current stock price of €6.10 is trading 89.4% above its estimated GF Value™ of €3.22. GuruFocus considers Agenus to be Significantly Overvalued.

Key valuation signals for FRA:AJ8:

  • Cyclically Adjusted Book per Share: €-13.34
  • GF Value™: €3.22 vs. price of €6.10 (89.4% above fair value)
  • GF Score™: 48/100 with 12 warning signs

No single metric tells the full story. See the FRA:AJ8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Agenus Business Description

Other Exchanges AGEN:USA
Address 3 Forbes Road, Lexington, MA, USA, 02421
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
48GF Score

Get the complete analysis for FRA:AJ8

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.10
Price
€3.22
GF Value